Privium Fund Management B.V.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 5, 2026), Privium Fund Management B.V. reported 60 stock positions worth $480.3 million. Its top holding was Tesla (TSLA) at 17.2% of the portfolio, followed by Shopify Class A (SHOP, 10.1%) and Spotify Technology (SPOT, 6.8%). Compared with Q4 2025, it opened 7 new positions, sold out of 4, added to 24 and reduced 17. The biggest buy was a new position in Esperion Therapeutics (ESPR) and the biggest sale Shopify Class A (SHOP, shares −1%).
- Most Recent 13F
- Q2 2026
- Location
- AMSTERDAM, P7
- CIK
- 0001795097
- Portfolio Value
- $480.3M (Q1 2026)
- SEC Filing
- 0001754960-26-000356 ↗ filed May 5, 2026
Holdings Value
Holdings 60 stocks · $480.3M
| TSLA Tesla Inc. | 17.18% | 222,000 | $82.5M | Reduce -2.8% |
| SHOP Shopify Inc. Class A | 10.05% | 407,000 | $48.3M | Reduce -0.7% |
| SPOT Spotify Technology SA | 6.76% | 67,000 | $32.5M | Reduce -1.5% |
| PLTR Palantir Technologies Inc. Class A | 6.09% | 200,000 | $29.3M | No change |
| AMZN Amazon.com Inc. | 5.42% | 125,000 | $26.0M | Add +3.3% |
| ARWR Arrowhead Pharmaceuticals Inc. | 4.79% | 366,936 | $23.0M | Reduce -7.8% |
| IONS Ionis Pharmaceuticals Inc. | 4.53% | 290,024 | $21.8M | Add +20.4% |
| LMND Lemonade Inc. | 3.33% | 255,259 | $16.0M | Add +2.8% |
| NVDA Nvidia Corp. | 2.94% | 81,000 | $14.1M | No change |
| COIN Coinbase Global Inc. Class A | 2.87% | 79,000 | $13.8M | No change |
| AMD Advanced Micro Devices | 2.63% | 62,000 | $12.6M | Add +3.3% |
| ASTS Ast Spacemobile Inc. | 2.50% | 145,000 | $12.0M | No change |
| SE Sea Ltd.-ADR | 2.38% | 138,000 | $11.4M | No change |
| IREN Iren Ltd. filed as IREN LIMITED | 2.28% | 320,150 | $11.0M | Add +14.3% |
| AXSM Axsome Therapeutics Inc. | 2.07% | 58,729 | $9.9M | Add +3.3% |
| ESPR Esperion Therapeutics Inc. | 1.88% | 3,299,441 | $9.0M | New |
| PRQR Proqr Therapeutics NV | 1.84% | 5,467,149 | $8.9M | Add +2.0% |
| BIIB Biogen Inc. | 1.67% | 43,800 | $8.0M | Reduce -40.4% |
| QURE Uniqure NV | 1.66% | 486,520 | $8.0M | Add +16.9% |
| RARE Ultragenyx Pharmaceutical Inc. | 1.59% | 364,802 | $7.6M | Add +2.0% |
| ARQT Arcutis Biotherapeutics Inc. | 1.57% | 320,972 | $7.6M | Add +4.9% |
| BMRN Biomarin Pharmaceutical Inc. | 1.09% | 92,305 | $5.2M | New |
| VRTX Vertex Pharmaceuticals Inc. | 1.06% | 11,355 | $5.1M | Add +21.4% |
| DNLI Denali Therapeutics Inc. | 1.02% | 254,857 | $4.9M | New |
| URGN Urogen Pharma Ltd. | 0.89% | 238,122 | $4.3M | Add +10.9% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.84% | 12,222 | $4.0M | New |
| VRDN Viridian Therapeutics Inc. | 0.71% | 173,516 | $3.4M | No change |
| KRYS Krystal Biotech Inc. | 0.60% | 11,170 | $2.9M | Reduce -8.2% |
| ABEV Ambev SA-ADR | 0.58% | 948,558 | $2.8M | Reduce -10.8% |
| ZLAB Zai Lab Ltd.-ADR | 0.52% | 132,189 | $2.5M | No change |
| BNTX Biontech SE-ADR | 0.50% | 27,000 | $2.4M | Reduce -18.9% |
| ENGN Engene Holdings Inc. | 0.50% | 352,087 | $2.4M | No change |
| CRSP Crispr Therapeutics AG | 0.42% | 42,874 | $2.0M | No change |
| MGTX Meiragtx Holdings PLC | 0.38% | 212,112 | $1.8M | Add +6.1% |
| WVE Wave Life Sciences Ltd. | 0.36% | 241,010 | $1.7M | Add +24.9% |
| STOK Stoke Therapeutics Inc. | 0.34% | 50,000 | $1.6M | Reduce -9.1% |
| FDMT 4D Molecular Therapeutics Inc. | 0.33% | 170,256 | $1.6M | Reduce -18.9% |
| BEAM Beam Therapeutics Inc. | 0.32% | 63,982 | $1.5M | Reduce -10.5% |
| MRNA Moderna Inc. | 0.32% | 29,994 | $1.5M | Reduce -39.5% |
| PFE Pfizer Inc. | 0.31% | 52,679 | $1.5M | Add +39.5% |
| LXEO Lexeo Therapeutics Inc. | 0.24% | 205,000 | $1.2M | Add +6.5% |
| RNAC Cartesian Therapeutics Inc. | 0.23% | 179,114 | $1.1M | Add +3.8% |
| MOH Molina Healthcare Inc. | 0.23% | 8,140 | $1.1M | New |
| SRPT Sarepta Therapeutics Inc. | 0.21% | 46,000 | $1.0M | Add +7.0% |
| SLB SLB Ltd. filed as SLB LIMITED | 0.20% | 18,451 | $948K | Reduce -52.5% |
| RCKT Rocket Pharmaceuticals Inc. | 0.18% | 242,146 | $867K | Add +42.3% |
| HIMS Hims & Hers Health Inc. | 0.17% | 40,000 | $830K | No change |
| TSHA Taysha Gene Therapies Inc. | 0.17% | 181,900 | $813K | Add +10.3% |
| NOV Nov Inc. | 0.16% | 42,026 | $791K | Reduce -20.9% |
| RIG Transocean Ltd. | 0.15% | 106,604 | $707K | Reduce -23.6% |
| SA Seabridge Gold Inc. | 0.15% | 24,828 | $704K | Add +4.5% |
| SD Sandridge Energy Inc. | 0.13% | 38,792 | $633K | No change |
| AUTL Autolus Therapeutics PLC | 0.10% | 363,430 | $502K | Add +11.4% |
| FATE Fate Therapeutics Inc. | 0.10% | 414,311 | $497K | Add +12.3% |
| VYGR Voyager Therapeutics Inc. | 0.10% | 120,000 | $463K | Add +26.3% |
| TDW Tidewater Inc. | 0.10% | 5,483 | $458K | No change |
| BTG B2GOLD Corp. | 0.09% | 96,477 | $437K | New |
| NE Noble Corp. PLC | 0.07% | 6,849 | $336K | Reduce -36.9% |
| PAAS Pan American Silver Corp. | 0.04% | 3,900 | $213K | New |
| URNM Sprott Uranium Miners ETF | 0.04% | 3,302 | $209K | Reduce -38.9% |
Portfolio Sells Q4 2025 → Q1 2026
| SHOP Shopify Inc. Class A | Reduce -0.7% | 10.05% | −2.10 |
| TSLA Tesla Inc. | Reduce -2.8% | 17.18% | −1.74 |
| MRK Merck & Co. Inc. | Sold out | 0.00% | −0.71 |
| BIIB Biogen Inc. | Reduce -40.4% | 1.67% | −0.71 |
| SPOT Spotify Technology SA | Reduce -1.5% | 6.76% | −0.51 |
| VZLA Vizsla Silver Corp. | Sold out | 0.00% | −0.21 |
| BNTX Biontech SE-ADR | Reduce -18.9% | 0.50% | −0.08 |
| ARWR Arrowhead Pharmaceuticals Inc. | Reduce -7.8% | 4.79% | −0.08 |
| SLB SLB Ltd. | Reduce -52.5% | 0.20% | −0.08 |
| VAL Valaris Ltd. | Sold out | 0.00% | −0.06 |
| BEAM Beam Therapeutics Inc. | Reduce -10.5% | 0.32% | −0.05 |
| NOMD Nomad Foods Ltd. | Sold out | 0.00% | −0.02 |
| URNM Sprott Uranium Miners ETF | Reduce -38.9% | 0.04% | −0.01 |
| NOV Nov Inc. | Reduce -20.9% | 0.16% | +0.01 |
| NE Noble Corp. PLC | Reduce -36.9% | 0.07% | +0.01 |
| STOK Stoke Therapeutics Inc. | Reduce -9.1% | 0.34% | +0.02 |
| FDMT 4D Molecular Therapeutics Inc. | Reduce -18.9% | 0.33% | +0.04 |
| RIG Transocean Ltd. | Reduce -23.6% | 0.15% | +0.04 |
| MRNA Moderna Inc. | Reduce -39.5% | 0.32% | +0.05 |
| KRYS Krystal Biotech Inc. | Reduce -8.2% | 0.60% | +0.05 |
| ABEV Ambev SA-ADR | Reduce -10.8% | 0.58% | +0.09 |
Portfolio Buys Q4 2025 → Q1 2026
| ESPR Esperion Therapeutics Inc. | New | 1.88% | +1.88 |
| BMRN Biomarin Pharmaceutical Inc. | New | 1.09% | +1.09 |
| IONS Ionis Pharmaceuticals Inc. | Add +20.4% | 4.53% | +1.03 |
| DNLI Denali Therapeutics Inc. | New | 1.02% | +1.02 |
| ALNY Alnylam Pharmaceuticals Inc. | New | 0.84% | +0.84 |
| IREN Iren Ltd. | Add +14.3% | 2.28% | +0.34 |
| AMZN Amazon.com Inc. | Add +3.3% | 5.42% | +0.28 |
| VRTX Vertex Pharmaceuticals Inc. | Add +21.4% | 1.06% | +0.27 |
| AMD Advanced Micro Devices | Add +3.3% | 2.63% | +0.26 |
| MOH Molina Healthcare Inc. | New | 0.23% | +0.23 |
| AXSM Axsome Therapeutics Inc. | Add +3.3% | 2.07% | +0.15 |
| PFE Pfizer Inc. | Add +39.5% | 0.31% | +0.13 |
| BTG B2GOLD Corp. | New | 0.09% | +0.09 |
| MGTX Meiragtx Holdings PLC | Add +6.1% | 0.38% | +0.09 |
| LMND Lemonade Inc. | Add +2.8% | 3.33% | +0.08 |
| RARE Ultragenyx Pharmaceutical Inc. | Add +2.0% | 1.59% | +0.08 |
| RCKT Rocket Pharmaceuticals Inc. | Add +42.3% | 0.18% | +0.07 |
| PAAS Pan American Silver Corp. | New | 0.04% | +0.04 |
| SRPT Sarepta Therapeutics Inc. | Add +7.0% | 0.21% | +0.04 |
| FATE Fate Therapeutics Inc. | Add +12.3% | 0.10% | +0.04 |
| VYGR Voyager Therapeutics Inc. | Add +26.3% | 0.10% | +0.03 |
| SA Seabridge Gold Inc. | Add +4.5% | 0.15% | +0.02 |
| TSHA Taysha Gene Therapies Inc. | Add +10.3% | 0.17% | +0.00 |
| RNAC Cartesian Therapeutics Inc. | Add +3.8% | 0.23% | +0.00 |
| AUTL Autolus Therapeutics PLC | Add +11.4% | 0.10% | −0.02 |
| URGN Urogen Pharma Ltd. | Add +10.9% | 0.89% | −0.03 |
| ARQT Arcutis Biotherapeutics Inc. | Add +4.9% | 1.57% | −0.06 |
| LXEO Lexeo Therapeutics Inc. | Add +6.5% | 0.24% | −0.11 |
| PRQR Proqr Therapeutics NV | Add +2.0% | 1.84% | −0.15 |
| QURE Uniqure NV | Add +16.9% | 1.66% | −0.18 |
| WVE Wave Life Sciences Ltd. | Add +24.9% | 0.36% | −0.24 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 61 | $544.2M | TSLA, SHOP, AMD, AMZN, IONS |
| Q1 2026 | 60 | $480.3M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q4 2025 | 57 | $543.1M | TSLA, SHOP, SPOT, PLTR, AMZN |
| Q3 2025 | 59 | $556.3M | TSLA, SPOT, SHOP, PLTR, AMZN |
| Q2 2025 | 55 | $463.5M | SPOT, TSLA, SHOP, PLTR, AMZN |
| Q1 2025 | 56 | $383.6M | SPOT, TSLA, SHOP, PLTR, SE |
| Q4 2024 | 59 | $437.0M | TSLA, SPOT, SHOP, AMZN, PLTR |
| Q3 2024 | 82 | $402.0M | TSLA, SPOT, SHOP, AMZN, ASTS |
| Q2 2024 | 85 | $358.2M | TSLA, SPOT, AMZN, SHOP, SNOW |
| Q1 2024 | 75 | $342.7M | SPOT, SHOP, TSLA, AMZN, SNOW |